Cite

HARVARD Citation

    Smith, G. et al. (n.d.). EP-2078: PROSPECT: Phase 2 rescanning of seromas in patients to evaluate CTV reduction in breast cancer. Radiotherapy and oncology. pp. S980-. [Online]. 
  
Back to record